Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation

被引：2
|
作者：
Yanada, Masamitsu [1 ]
Uchida, Naoyuki [2 ]
Ichinohe, Tatsuo [3 ]
Fukuda, Takahiro [4 ]
Kanda, Junya [5 ]
Kanda, Yoshinobu [6 ,7 ]
Atsuta, Yoshiko [8 ,9 ]
Nakasone, Hideki [7 ]
机构：
[1] Aichi Canc Ctr, Nagoya, Aichi, Japan
[2] Toranomon Gen Hosp, Tokyo, Japan
[3] Hiroshima Univ, Res Inst Radiat Biol & Med, Hiroshima, Japan
[4] Natl Canc Ctr, Tokyo, Japan
[5] Kyoto Univ, Grad Sch Med, Kyoto, Japan
[6] Jichi Med Univ, Shimotsuke, Tochigi, Japan
[7] Jichi Med Univ Saitama Med Ctr, Saitama, Japan
[8] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan
[9] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
来源：
BONE MARROW TRANSPLANTATION | 2021年 / 56卷 / 07期
关键词：
RISK-ASSESSMENT;
D O I：
10.1038/s41409-021-01236-7
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1720 / 1722
页数：3
相关论文
共 50 条
  • [41] PRE-TRANSPLANT PULMONARY FUNCTION AND DAY 100 NON-RELAPSE MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Basa, S. K.
    Liesveld, J. L.
    Trawick, D. R.
    Fernandez, D.
    Nichols, D.
    Fisher, S. G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 54 - 54
  • [42] Hematopoietic cell transplantation-specific comorbidity index to predict non-relapse mortality and survival after allografting.
    Kato, R
    Fukuda, T
    Usui, E
    Yamasaki, S
    Maruyama, D
    Morita, Y
    Kim, SW
    Mori, SI
    Tanosaki, R
    Tajima, K
    Heike, Y
    Makimoto, A
    Tobinai, K
    Takaue, Y
    BLOOD, 2005, 106 (11) : 766A - 767A
  • [43] Pre- Transplant Ferritin Predicts Overall Survival and Non-Relapse Mortality in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis
    Andrade-Gonzalez, Xavier A.
    Tefferi, Ayalew
    Pardanani, Animesh
    Gangat, Naseema
    Patnaik, Mrinal M.
    Palmer, Jeanne M.
    Kharfan-Dabaja, Mohamed A.
    Litzow, Mark
    Shah, Mithun Vinod
    Hogan, William J.
    Alkhateeb, Hassan B.
    BLOOD, 2020, 136
  • [44] Administration of Mogamulizumab before Allogeneic Hematopoietic Cell Transplantation Against ATLL Might Increase Risks of Acute Gvhd and Non-Relapse Mortality
    Inoue, Yoshitaka
    Fuji, Shigeo
    Tanosaki, Ryuji
    Ito, Reiko
    Tanaka, Takashi
    Inamoto, Yoshihiro
    Okinaka, Keiji
    Kurosawa, Saiko
    Kim, Sung-Won
    Yamashita, Takuya
    Fukuda, Takahiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S198 - S198
  • [45] Impact of Nutrition on Non-Relapse Mortality and Acute Graft Versus Host Disease during Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
    Beckerson, Julie
    Szydlo, Richard M.
    Hickson, Mary
    Mactier, Catriona E.
    Innes, Andrew
    Gabriel, Ian H.
    Palanicawandar, Renuka
    Kanfer, Edward J.
    Macdonald, Donald
    Milojkovic, Dragana
    Rahemtulla, Amin
    Chaidos, Aristeidis
    Karadimitris, Anastasios
    Olavarria, Eduardo
    Apperley, Jane F.
    Pavlu, Jiri
    BLOOD, 2016, 128 (22)
  • [46] Pre-transplant serum hepcidin does not correlate with non-relapse morbidity and mortality after allogeneic haematopoietic cell transplantation in patients with AML and MDS
    Al-Ali, H.
    Jaekel, N.
    Krahl, R.
    Edel, E.
    Wickenhauser, C.
    Westermann, M.
    Leiblein, S.
    Liebert, U. G.
    Hehme, M.
    Niederwieser, D.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S167 - S167
  • [47] Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non-relapse mortality after allogeneic hematopoietic stem cell transplantation
    Takeshita, Junko
    Kimura, Shun-ichi
    Nakasone, Hideki
    Kawamura, Shunto
    Nakamura, Yuhei
    Kawamura, Masakatsu
    Yoshino, Nozomu
    Misaki, Yukiko
    Yoshimura, Kazuki
    Matsumi, Shimpei
    Gomyo, Ayumi
    Tamaki, Masaharu
    Akahoshi, Yu
    Kusuda, Machiko
    Kameda, Kazuaki
    Wada, Hidenori
    Sato, Miki
    Kako, Shinichi
    Kanda, Yoshinobu
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (05)
  • [48] Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Kadri, Yasmine
    Phan, Michelle
    Bambace, Nadia
    Bernard, Lea
    Cohen, Sandra
    Delisle, Jean-Sebastien
    Kiss, Thomas
    Lachance, Sylvie
    Roy, Denis-Claude
    Sauvageau, Guy
    Veilleux, Olivier
    Roy, Jean
    Ahmad, Imran
    CURRENT ONCOLOGY, 2022, 29 (08) : 5955 - 5962
  • [49] Validation of Pre-Transplantation Plasma ST2 Levels As a Prognostic Marker of 1-Year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation
    Gjaerde, Lars Klingen
    Ostrowski, Sisse Rye
    Schierbeck, Frederikke
    Andersen, Niels Smedegaard
    Friis, Lone Smidstrup
    Kornblit, Brian Thomas
    Petersen, Soren Lykke
    Schjodt, Ida
    Sengeloev, Henrik
    BLOOD, 2021, 138
  • [50] Comorbidities Exert Regimen-Specific Effects on Non-Relapse Mortality in Allogeneic Stem Cell Transplantation
    Fein, Joshua
    Labopin, Myriam
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Danylesko, Ivetta
    Nadav, Furie
    Shimoni, Avichai
    Nagler, Arnon
    Shouval, Roni
    BONE MARROW TRANSPLANTATION, 2018, 53 : 16 - 17
12345